LEBWOHL DAVID (EVP, Chief Medical Officer) received a stock award from INTELLIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001193125-26-088258
Officer· EVP, Chief Medical Officer
Since Apr 2020
+24.15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
24.15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.94K
Price / share
—
Trade value
—
% of position
8.2%
3/1/2026
121.25K→131.19K
Total
Net shares
+9.94K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +9.94K | — | — | 8.2% | 121.25K | 131.19K |
| Total | +9.94K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
14.20K shares
Shares
+14.20K
Strike price
13.78
Held after
14.20K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock14.20K shares | 3/1/2026 | A · Award | +14.20K | 13.78 | — | 14.20K |